NTA_AVIAU
ID NTA_AVIAU Reviewed; 36 AA.
AC A0A3F2YLP5;
DT 11-DEC-2019, integrated into UniProtKB/Swiss-Prot.
DT 11-DEC-2019, sequence version 2.
DT 25-MAY-2022, entry version 13.
DE RecName: Full=Kappa-theraphotoxin-Aa1a {ECO:0000303|PubMed:30149017};
DE Short=Kappa-TRTX-Aa1a {ECO:0000303|PubMed:30149017};
DE AltName: Full=Avicularia aurantiaca;
OS Avicularia aurantiaca (Yellow-banded pinktoe tarantula).
OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC Mygalomorphae; Theraphosidae; Avicularia.
OX NCBI_TaxID=2652665;
RN [1]
RP PROTEIN SEQUENCE, STRUCTURE BY NMR, FUNCTION, SYNTHESIS, DISULFIDE BOND,
RP AMIDATION AT ILE-36, SUBCELLULAR LOCATION, MASS SPECTROMETRY, AND
RP PHARMACEUTICAL.
RC TISSUE=Venom;
RX PubMed=30149017; DOI=10.1016/j.bcp.2018.08.038;
RA Ma L., Chin Y.K.Y., Dekan Z., Herzig V., Chow C.Y., Heighway J., Lam S.W.,
RA Guillemin G.J., Alewood P.F., King G.F.;
RT "Novel venom-derived inhibitors of the human EAG channel, a putative
RT antiepileptic drug target.";
RL Biochem. Pharmacol. 158:60-72(2018).
CC -!- FUNCTION: Selective inhibitor of voltage-gated potassium channel
CC Kv10.1/KCNH1/EAG1 (IC(50)=637 nM). It acts by shifting the voltage
CC dependence of channel activation in a depolarising direction. It shows
CC a 100% inhibition at saturating concentrations, shows fast on-rates and
CC is reversible. It also slightly affects channel inactivation, when the
CC membrane is highly depolarised (>+80 mV).
CC {ECO:0000269|PubMed:30149017}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:30149017}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC {ECO:0000305|PubMed:30149017}.
CC -!- DOMAIN: The presence of a 'disulfide through disulfide knot'
CC structurally defines this protein as a knottin.
CC {ECO:0000269|PubMed:30149017}.
CC -!- MASS SPECTROMETRY: Mass=4148.217; Method=MALDI; Note=Monoisotopic
CC mass.; Evidence={ECO:0000269|PubMed:30149017};
CC -!- PHARMACEUTICAL: Could be used as informative lead for the development
CC of novel antiepileptic drugs, as well as pharmacological tool for
CC probing Kv10.1/KCNH1/EAG1 function. {ECO:0000305|PubMed:30149017}.
CC -!- MISCELLANEOUS: Weakly inhibits Nav1.2/SCN2A (IC(50)=1449 nM),
CC Nav1.7/SCN9A (IC(50)=1528 nM), Nav1.5/SCN5A (IC(50)=7316), and
CC Kv11.1/KCNH2/ERG1 (IC(50)=8511 nM). {ECO:0000269|PubMed:30149017}.
CC -!- SIMILARITY: Belongs to the neurotoxin 10 (Hwtx-1) family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR PDB; 5WLX; NMR; -; A=1-36.
DR PDBsum; 5WLX; -.
DR AlphaFoldDB; A0A3F2YLP5; -.
DR BMRB; A0A3F2YLP5; -.
DR SMR; A0A3F2YLP5; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0008200; F:ion channel inhibitor activity; IEA:InterPro.
DR GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR InterPro; IPR011696; Huwentoxin-1.
DR Pfam; PF07740; Toxin_12; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Amidation; Direct protein sequencing; Disulfide bond;
KW Ion channel impairing toxin; Pharmaceutical;
KW Potassium channel impairing toxin; Secreted; Toxin;
KW Voltage-gated potassium channel impairing toxin.
FT CHAIN 1..36
FT /note="Kappa-theraphotoxin-Aa1a"
FT /evidence="ECO:0000269|PubMed:30149017"
FT /id="PRO_0000448842"
FT MOD_RES 36
FT /note="Isoleucine amide"
FT /evidence="ECO:0000269|PubMed:30149017"
FT DISULFID 3..18
FT /evidence="ECO:0000269|PubMed:30149017,
FT ECO:0007744|PDB:5WLX"
FT DISULFID 10..23
FT /evidence="ECO:0000269|PubMed:30149017,
FT ECO:0007744|PDB:5WLX"
FT DISULFID 17..30
FT /evidence="ECO:0000269|PubMed:30149017,
FT ECO:0007744|PDB:5WLX"
FT TURN 25..27
FT /evidence="ECO:0007829|PDB:5WLX"
SQ SEQUENCE 36 AA; 4158 MW; B5802DF9E8E06B84 CRC64;
GDCHKFLGWC RGEKDPCCEH LTCHVKHGWC VWDGTI